MedPath

The effect of anti-inflammatory drug and acetaminophen on postpartum hypertensio

Phase 2
Recruiting
Conditions
Postpartum hypertension.
Eclampsia in the puerperium
O15.2
Registration Number
IRCT20210823052269N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
110
Inclusion Criteria

Cesarean candidate patients
No chronic liver, kidney, hemorrhagic disorders
No history of allergy to nonsteroidal anti-inflammatory drugs and acetaminophen
Severe preeclampsia or preeclampsia added to chronic hypertension with severe symptoms

Exclusion Criteria

Increase in liver enzyme levels higher than 200 mg / dL
Increase in serum creatinine higher than 2 mg / d

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary variable: Duration of high blood pressure. Timepoint: Measure blood pressure for 24 hours every hour and then every 4 hours. Method of measurement: Mercury sphygmomanometer.;Primary variable: Frequency of need to use short acting antihypertensive drugs. Timepoint: Measure blood pressure for 24 hours every hour and then every 4 hours. Method of measurement: Counting.
Secondary Outcome Measures
NameTimeMethod
Frequency of need to use short-acting antihypertensive drugs to control sudden hypertension in both groups receiving acetaminophen and nonsteroidal anti-inflammatory drugs. Timepoint: At the beginning of the study (before the intervention), for 24 hours every hour and then every 4 hours. Method of measurement: Counting.
© Copyright 2025. All Rights Reserved by MedPath